Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

OPKO Acquires ModeX Therapeutics

Learn More

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

Sep 14, 2021

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

Aug 30, 2021

OPKO Health to Participate in Two Upcoming Investment Conferences

Aug 30, 2021

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program

Aug 26, 2021

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business

Aug 16, 2021

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

Jul 29, 2021

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

Jul 20, 2021

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

Jul 12, 2021

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

Jul 8, 2021

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

Jun 22, 2021
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...47
    Next
    © 2022 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap